Ganesh V. Kaundinya
2015
In 2015, Ganesh V. Kaundinya earned a total compensation of $1.9M as Chief Scientific Officer and Senior Vice President, Research at Momenta Pharmaceuticals, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $187,924 |
|---|---|
| Option Awards | $310,065 |
| Salary | $432,708 |
| Stock Awards | $927,139 |
| Other | $13,014 |
| Total | $1,870,850 |
Kaundinya received $927.1K in stock awards, accounting for 50% of the total pay in 2015.
Kaundinya also received $187.9K in non-equity incentive plan, $310.1K in option awards, $432.7K in salary and $13K in other compensation.
Rankings
In 2015, Ganesh V. Kaundinya's compensation ranked 4,988th out of 13,638 executives tracked by ExecPay. In other words, Kaundinya earned more than 63.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,988 out of 13,638 | 63rd |
Division Manufacturing | 1,841 out of 5,190 | 65th |
Major group Chemicals And Allied Products | 659 out of 1,854 | 65th |
Industry group Drugs | 524 out of 1,528 | 66th |
Industry Biological Products, Except Diagnostic Substances | 87 out of 254 | 66th |
Source: SEC filing on April 27, 2017.
Kaundinya's colleagues
We found five more compensation records of executives who worked with Ganesh V. Kaundinya at Momenta Pharmaceuticals in 2015.
2015
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2015
James Roach
Momenta Pharmaceuticals
Chief Medical Officer
2015
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2015
Richard Shea
Momenta Pharmaceuticals
Chief Financial Officer
2015
Matthew Ottmer
Momenta Pharmaceuticals